Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
-
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
-
Toccata Announces Canaro, a Saskatchewan-Built Remote Monitoring Platform with Satellite Connectivity
-
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026
-
Greenridge Announces Signing of Sale and Purchase Agreement With Leading Southeast Asian Investor for $3.0 Million Private Placement
-
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
-
Steelworkers in Canada welcome American support against Trump tariffs
-
Abercrombie & Fitch Co. to Report Second Quarter 2026 Results on August 26, 2026
-
Mobilicom to Report Financial and Operational Results for the Six Months Ended June 30, 2026, on Thursday, August 13, 2026
-
ATIF Holdings Limited Enters into Definitive Agreement to Acquire GoldCoin Labs Limited
-
Wearable Devices Announces Pricing of $3.3 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
-
From Sponsorship to Commercial Partnership: GSJJ Custom Challenge Coins Case Study with South Carolina Fraternal Order of Police (SCFOP)
-
Space-Eyes and McKinley Acquisition Corp. Announce Definitive Business Combination Agreement to Deliver AI-Driven Counter Drone Technology and Geospatial Intelligence Worldwide
-
Star Group, L.P. to Host Fiscal 2026 Third Quarter Webcast and Conference Call August 6, 2026
-
Swarmer Announces Date for Second Quarter 2026 Results and Business Updates
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October
-
Hudbay Announces Correction to its Upcoming Dividend Record and Payment Dates
-
Castellum Schedules Second Quarter 2026 Earnings Release and Conference Call
-
Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada
-
Abercrombie & Fitch Co. to Report Second Quarter 2026 Results on August 26, 2026
-
Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET
-
J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
IES Holdings Reports Fiscal 2026 Third Quarter Results and Announces Two-for-One Stock Split
-
Notice on partial early redemption of bonds
-
YXT.com Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
-
Dragonfly Energy Announces Strategic Acquisition of Dakota Lithium Assets, Expanding Into New Markets
-
Multilogin Repositions as a Cloud Phone Platform for Managing Multiple Social Media Accounts, Cuts Entry Price to $7.08/Month
-
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
-
Banco Itaú Chile Announces Second Quarter 2026 Management Commentary
-
DCX Announces Open-Market Share Purchase by Chief Executive Officer
-
IBN.Ai Launches Publicly Traded IBNAi Companion Coin / Token ($IBNAi)
-
IBN.Ai Launches Publicly Traded IBNAi Companion Coin / Token ($IBNAi)
-
Director/PDMR Shareholding
-
Transaction in Own Shares
-
TransAlta Reports Strong Second Quarter Results and Reaffirms Guidance
-
Ocugen to Participate in Upcoming August Investor Conferences
-
GCL Announces Fiscal Year 2026 Financial Results
-
George Weston Limited Reports Adjusted Diluted Net Earnings Per Common Share Growth of 12.9% in the Second Quarter
-
Radiopharm Theranostics Reports Business Update
-
The Orange Giant Announces ZHAI Has Entered Full Production
-
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
-
Balchem Corporation Reports Second Quarter 2026 Financial Results
-
LEO Technologies Launches Verus ION, an Agentic AI-Powered Unified Intelligence and Investigative Solution for Corrections and Public Safety
-
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Green Thumb Expands Pennsylvania Retail Footprint with the Opening of RISE Dispensary Hanover
